Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 31: 298-302, 1985;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, A. H.
Right arrow Articles by Gornet, T. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, A. H.
Right arrow Articles by Gornet, T. G.

Clinical Chemistry, Vol 31, 298-302, Copyright © 1985 by American Association for Clinical Chemistry

Preparation of urine samples for liquid-chromatographic determination of catecholamines: bonded-phase phenylboronic acid, cation-exchange resin, and alumina adsorbents compared

AH Wu and TG Gornet

We compared results for the liquid-chromatographic determination of free norepinephrine and epinephrine in urine after purifying the catechols by the following methods: (a) acid-washed alumina, (b) weak cation-exchange resin (WCX), (c) a combination of weak cation-exchange resin followed by alumina (WCX-alumina), and (d) commercially available phenylboronic acid adsorbent. We evaluated analytical specificity, sensitivity, recovery, and turnaround time. The WCX-alumina combination produced the most sensitive and specific chromatograms for urinary catecholamines; the other methods took less processing time. Neither WCX nor alumina alone was suitable for routine work because of chromatographic interferences in a significant proportion of urines. The phenylboronic acid method is adequately sensitive and specific for norepinephrine and epinephrine, and samples can be assayed faster. Thus it provides a compromise between the high analytical performance of the WCX-alumina method and the speed of the WCX and alumina methods.


The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
K. Mussig, A. Pfafflin, H.-U. Haring, and E. D. Schleicher
Dipyrone (Metamizole) Metabolites Interfere with HPLC Analysis of Plasma Catecholamines but Not with the Determination of Urinary Catecholamines
Clin. Chem., September 1, 2006; 52(9): 1829 - 1831.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. M. Kushnir, F. M. Urry, E. L. Frank, W. L. Roberts, and B. Shushan
Analysis of Catecholamines in Urine by Positive-Ion Electrospray Tandem Mass Spectrometry
Clin. Chem., February 1, 2002; 48(2): 323 - 331.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
F. Petraglia, M. C. Hatch, R. Lapinski, M. Stomati, F. M. Reis, L. Cobellis, and G. S. Berkowitz
Lack of Effect of Psychosocial Stress on Maternal Corticotropin-Releasing Factor and Catecholamine Levels at 28 Weeks' Gestation
Reproductive Sciences, April 1, 2001; 8(2): 83 - 88.
[Abstract] [PDF]


Home page
Clin. Chem.Home page
J. Wassell, P. Reed, J. Kane, and C. Weinkove
Freedom from Drug Interference in New Immunoassays for Urinary Catecholamines and Metanephrines
Clin. Chem., December 1, 1999; 45(12): 2216 - 2223.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. Eden Engstrom, F. A. Karlsson, and L. Wide
Gender Differences in Diurnal Growth Hormone and Epinephrine Values in Young Adults during Ambulation
Clin. Chem., August 1, 1999; 45(8): 1235 - 1239.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Dutton, A. J. Hodgkinson, G. Hutchinson, and N. B. Roberts
Evaluation of a New Method for the Analysis of Free Catecholamines in Plasma Using Automated Sample Trace Enrichment with Dialysis and HPLC
Clin. Chem., March 1, 1999; 45(3): 394 - 399.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Shigematsu, M. Hamada, H. Okayama, Y. Hara, Y. Hayashi, K. Kodama, K. Kohara, and K. Hiwada
Left Ventricular Hypertrophy Precedes Other Target-Organ Damage in Primary Aldosteronism
Hypertension, March 1, 1997; 29(3): 723 - 727.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American Association for Clinical Chemistry.